Trial
NCT05947461
Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac
UnknownTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Air Force Military Medical University, China
Collaborators
—
Condition
Post-ERCP Acute Pancreatitis
Intervention
100mg diclofenac
Why stopped
The data from the interim analysis showed a opposite trend predicting possible of benefit of indomethacin and conditional power analysis revealed a low probability of confirming the benefit of diclofenac if this trial will be continued.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-28